Physician

David A Buck, M.D.

According to 2025 Medicare claims, David Buck, M.D. (NPI: 1952377194) practices radiation oncology in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (NPI: 1487621496; TIN: 541922084) and primary practice location at 24014-1838. Buck is affiliated with the Doctors Connected (ACO ID: A4949), participating under the MSSP model.

Buck's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 615 traditional Medicare patients, billed 5,053 HCPCS/CPT codes, and received $371,969 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 438 prescription claims across 166 beneficiaries totaling $9,400 in drug costs, led by Tolterodine Tartrate Er (Tolterodine Tartrate). DME data shows 24 claims. Open Payments data shows 6 records totaling $539,276. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $14,400 and ending at $9,400. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	546	4,924	$302,038
2016	678	6,121	$378,754
2017	648	6,393	$419,102
2018	626	5,498	$368,974
2019	733	5,419	$380,774
2020	649	6,239	$416,562
2021	594	5,705	$409,233
2022	612	6,786	$471,983
2023	613	5,185	$366,649
2024	615	5,053	$371,969

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	121	338	$14,400
2016	134	376	$14,175
2017	119	317	$7,695
2018	93	207	$7,068
2019	111	231	$11,094
2020	137	272	$7,723
2021	142	295	$7,059
2022	180	444	$12,956
2023	173	407	$31,061
2024	166	438	$9,400

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	63	$10,845
2016	N/R	41	$5,804
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	24	$1,019

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77427	Radiation treatment management, 5 treatment sessions	141	551	$144
77263	Complex radiation therapy planning	148	152	$124
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	333	459	$44
77014	Ct guidance for insertion of radiation therapy fields	140	1,737	$38
77300	Calculation of radiation therapy dose	142	356	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tolterodine Tartrate Er	Tolterodine Tartrate	11	810	$1,767
Lidocaine Hcl Viscous	Lidocaine Hcl	80	411	$1,715
Mometasone Furoate	Mometasone Furoate	79	1,705	$1,375
Tamsulosin Hcl	Tamsulosin Hcl	94	4,695	$775
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	165	$399

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	12	$525
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest	Y	N/R	12	$494

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$1,743	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$537,533	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David A. Buck, M.D.?

Tedicare shows public-source Medicare data for David A. Buck, M.D. (NPI 1952377194), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David A. Buck, M.D. have ACO affiliation data?

David A. Buck, M.D. is shown with ACO affiliation data for Doctors Connected (MSSP, ACO ID A4949).

What billing organization is linked to David A. Buck, M.D.?

David A. Buck, M.D. is linked to ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (billing NPI 1487621496) in the available physician profile data.

Does David A. Buck, M.D. have Open Payments data?

David A. Buck, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.